2-ODA | CAS#514-10-3 | Plasmodium infection inhibitor

MedKoo Cat#: 592076 | Name: 2-ODA

Description:

WARNING: This product is for research use only, not for human or veterinary use.

2-ODA inhibitor of Plasmodium infections.

Chemical Structure

2-ODA

CAS#514-10-3

Theoretical Analysis

MedKoo Cat#: 592076

Name: 2-ODA

CAS#: 514-10-3

Chemical Formula: C18H32O2

Exact Mass: 280.2402

Molecular Weight: 280.45

Elemental Analysis: C, 77.09; H, 11.50; O, 11.41

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

2-ODA

IUPAC/Chemical Name

2-Octadecynoic Acid

InChi Key

WEAGGGHXTMXZQA-UHFFFAOYSA-N

InChi Code

InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-15H2,1H3,(H,19,20)

SMILES Code

CCCCCCCCCCCCCCCC#CC(O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 280.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Carballeira NM, Bwalya AG, Itoe MA, Andricopulo AD, Cordero-Maldonado ML, Kaiser M, Mota MM, Crawford AD, Guido RV, Tasdemir D. 2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes. Bioorg Med Chem Lett. 2014 Sep 1;24(17):4151-7. doi: 10.1016/j.bmcl.2014.07.050. Epub 2014 Jul 24. PubMed PMID: 25103602; PubMed Central PMCID: PMC4146677. 2: Yuasa J, Mukai R, Hasegawa Y, Kawai T. Ratiometric luminescence thermometry based on crystal-field alternation at the extremely narrow ⁵D₀ → ⁷F₂ transition band of europium(III). Chem Commun (Camb). 2014 Jul 28;50(59):7937-40. doi: 10.1039/c4cc00704b. PubMed PMID: 24686443. 3: Carballeira NM. Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids. Chem Phys Lipids. 2013 Jul-Aug;172-173:58-66. doi: 10.1016/j.chemphyslip.2013.05.002. Epub 2013 May 28. Review. PubMed PMID: 23727443; PubMed Central PMCID: PMC4110683. 4: Jiao C, Li F, Zhang J, Li Z, Wang S, Wang Z, Yu H, Li Z, Liu S, Wang Z, Jiang X, Sun L, Xu F. Syntheses, structures and chemical sensing properties of three complexes with mixed ligands of carboxylate and bipyridine. Dalton Trans. 2013 Feb 7;42(5):1346-51. doi: 10.1039/c2dt31867a. Epub 2012 Nov 22. PubMed PMID: 23172111. 5: Siddiqi ZA, Sharma PK, Shahid M, Khalid M, Anjuli, Siddique A, Kumar S. Superoxide scavenging and antimicrobial activities of novel transition metal complexes of oxydiacetate dianion as primary ligand: spectral characterization, cyclic voltammetric investigations and crystal structure. Eur J Med Chem. 2012 Nov;57:102-11. doi: 10.1016/j.ejmech.2012.08.043. Epub 2012 Sep 7. PubMed PMID: 23047227. 6: Carballeira NM, Cartagena M, Sanabria D, Tasdemir D, Prada CF, Reguera RM, Balaña-Fouce R. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani. Bioorg Med Chem Lett. 2012 Oct 1;22(19):6185-9. doi: 10.1016/j.bmcl.2012.08.019. Epub 2012 Aug 10. PubMed PMID: 22932312; PubMed Central PMCID: PMC3483883. 7: Zhou Q, Yang F, Liu D, Peng Y, Li G, Shi Z, Feng S. Synthesis, structures, and magnetic properties of three fluoride-bridged lanthanide compounds: effect of bridging fluoride ions on magnetic behaviors. Inorg Chem. 2012 Jul 16;51(14):7529-36. doi: 10.1021/ic300125y. Epub 2012 Jul 2. PubMed PMID: 22747520. 8: León IE, Etcheverry SB, Parajón-Costa BS, Baran EJ. Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture. Biol Trace Elem Res. 2012 Jun;147(1-3):403-7. doi: 10.1007/s12011-012-9322-z. Epub 2012 Jan 13. PubMed PMID: 22246791. 9: Lennartson A, Håkansson M. Hydrogen-bonded network structures in dipyridinium, bis(2-methylpyridinium), bis(3-methylpyridinium) and bis(4-methylpyridinium) dioxidobis(oxydiacetato)uranate(VI). Acta Crystallogr C. 2010 Mar;66(Pt 3):m69-74. doi: 10.1107/S0108270109053839. Epub 2010 Feb 3. PubMed PMID: 20203398; PubMed Central PMCID: PMC2855580. 10: Tian G, Rao L, Oliver A. Symmetry and optical spectra: a "silent" 1 : 2 Np(V)-oxydiacetate complex. Chem Commun (Camb). 2007 Oct 28;(40):4119-21. Epub 2007 Aug 6. PubMed PMID: 17925948. 11: Di Nicola C, Galindo A, Hanna JV, Marchetti F, Pettinari C, Pettinari R, Rivarola E, Skelton BW, White AH. Synthesis and spectroscopic and X-ray structural characterization of R2Sn(IV)-oxydiacetate and -iminodiacetate complexes. Inorg Chem. 2005 May 2;44(9):3094-102. PubMed PMID: 15847414. 12: Rizzi AC, Calvo R, Baggio R, Garland MT, Peña O, Perec M. Carboxylate-bridged copper(II)-lanthanide(III) complexes [(Cu(3)Ln(2)(oda)(6)(H(2)O)(6)).12H(2)O](n)(Ln = Dy, Ho, Er, Y; oda = oxydiacetate). Inorg Chem. 2002 Oct 21;41(21):5609-14. PubMed PMID: 12377061.